The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study.

By D. Silverberg, D. Wexler, D. Sheps, M. Blum, G. Keren, R. Baruch, D. Schwartz, T. Yachnin, S. Steinbruch, I. Shapira and 2 more. Journal of the American College of Cardiology, 2001

696 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Hematology

View Paper: https://www.semanticscholar.org/paper/e68b54ef0d90b0a48a018e1807d920d850f0e285

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

1. T. Horwich
2. G. Fonarow

Citations in the corpus

• Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure. (2002, background): “Initial studies suggest that treatment of anemia is beneficial in HF (8).”
• Anemia Is Common in Heart Failure and Is Associated With Poor Outcomes: Insights From a Cohort of 12 065 Patients With New-Onset Heart Failure (2003, neutral): “... 77.311* 76.412 Male sex 944 (45)* 570 (47)* 4972 (50) Diabetes 532 (26) 347 (29)* 2346 (24) Hypertension 738 (35)* 452 (37)* 2829 (28) COPD 625 (30) 372 (31) 2879 (28) Hyperlipidemia 78 (4) 58 (5) 349 (4) Ischemic heart disease 868 (42)* 540 (45)* 3805 (38) Cerebrovascular disease 107 (5) 58 (5)”